Skip to main content
. 2020 Jan 27;15(1):e0227549. doi: 10.1371/journal.pone.0227549

Fig 4. In-vitro thymidine phosphorylase inhibitory activities of 4-hydroxylbenzohydarazides (1–29).

Fig 4